Perillyl alcohol alleviates amyloid-β peptides-induced mitochondrial dysfunction and cytotoxicity in SH-SY5Y cells

Int J Biol Macromol. 2018 Apr 1:109:1029-1038. doi: 10.1016/j.ijbiomac.2017.11.082. Epub 2017 Nov 14.

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common type of dementia in elderly ( >65years of age). Excessive extra cellular deposits of amyloid beta (Aβ) are a pathological feature of AD. Aβ can cause cell death through oxidative damage; recent studies have implicated opening of mPTP as a detrimental event in AD-related mitochondrial dysfunctions. Over the past few years, natural compounds with antioxidant properties have shown promise for intervention in AD.

MeSH terms

  • Amyloid beta-Peptides / pharmacology*
  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cytochromes c / metabolism
  • DNA Fragmentation / drug effects
  • Drug Synergism
  • Humans
  • Ion Channel Gating / drug effects
  • Membrane Potential, Mitochondrial / drug effects
  • Mitochondria / drug effects*
  • Mitochondria / metabolism*
  • Mitochondrial Membrane Transport Proteins / metabolism
  • Mitochondrial Permeability Transition Pore
  • Monoterpenes / pharmacology*
  • Reactive Oxygen Species / metabolism

Substances

  • Amyloid beta-Peptides
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • Monoterpenes
  • Reactive Oxygen Species
  • perillyl alcohol
  • Cytochromes c